- Report
- July 2024
- 153 Pages
Global
From €3164EUR$3,400USD£2,646GBP
€3955EUR$4,250USD£3,308GBP
- Report
- August 2025
- 155 Pages
Global
From €3350EUR$3,599USD£2,801GBP
- Report
- July 2025
- 178 Pages
Global
From €4606EUR$4,949USD£3,852GBP
- Report
- June 2025
- 152 Pages
Latin America
From €3350EUR$3,599USD£2,801GBP
- Report
- May 2025
- 115 Pages
Australia
From €3350EUR$3,599USD£2,801GBP
- Report
- May 2025
- 165 Pages
Global
From €4514EUR$4,850USD£3,775GBP
- Report
- March 2026
- 150 Pages
Germany
From €4514EUR$4,850USD£3,775GBP
- Report
- February 2026
- 150 Pages
China
From €4514EUR$4,850USD£3,775GBP
- Report
- September 2025
- 150 Pages
Global
From €4514EUR$4,850USD£3,775GBP
- Report
- August 2025
- 150 Pages
Global
From €4514EUR$4,850USD£3,775GBP
- Report
- July 2025
- 150 Pages
Global
From €4514EUR$4,850USD£3,775GBP
- Report
- March 2025
- 150 Pages
Global
From €4514EUR$4,850USD£3,775GBP
- Report
- July 2025
- 81 Pages
Middle East, Africa
From €3211EUR$3,450USD£2,685GBP
- Report
- July 2025
- 197 Pages
Global
From €4607EUR$4,950USD£3,853GBP
- Report
- May 2025
- 199 Pages
Global
From €4607EUR$4,950USD£3,853GBP
- Report
- May 2025
- 110 Pages
Global
From €2746EUR$2,950USD£2,296GBP
- Report
- May 2025
- 89 Pages
North America
From €2746EUR$2,950USD£2,296GBP
- Report
- March 2025
- 78 Pages
North America
From €2746EUR$2,950USD£2,296GBP
- Report
- March 2025
- 111 Pages
Global
From €2746EUR$2,950USD£2,296GBP
- Report
- January 2025
- 111 Pages
Europe
From €3211EUR$3,450USD£2,685GBP

The Bioactive Compound market is a subset of the biotechnology industry that focuses on the development and production of compounds with biological activity. These compounds are used in a variety of applications, including drug discovery, diagnostics, and therapeutics. Bioactive compounds are typically derived from natural sources, such as plants, animals, and microorganisms, and are often modified to enhance their activity. The market is driven by the increasing demand for new and improved treatments for a variety of diseases, as well as the need for more efficient and cost-effective drug discovery processes.
The Bioactive Compound market is highly competitive, with a number of companies offering a range of products and services. Major players in the market include Merck, Pfizer, Novartis, and Roche. Other notable companies include AbbVie, AstraZeneca, and GlaxoSmithKline. Show Less Read more